Long-term outcomes of infliximab in patients with Behcet's disease-associated uveitis. Yamana S, Hasegawa E, Takeda A, Yawata N, et al. Int Ophthalmol 2022 Sep 4. pii: 10.1007/s10792-022-02495.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yamana S, Hasegawa E, Takeda A, Yawata N, et al. Long-term outcomes of infliximab in patients with Behcet's disease-associated uveitis. Int Ophthalmol 2022 Sep 4. pii: 10.1007/s10792-022-02495.
PMID: 36057758